Determining the costs of institutional review boards

IRB Ethics and Human Research

Volumn 29, Issue 2, 2007, Pages 7-13

  Speckman, Jeanne L ^a   Byrne, Margaret M ^b   Gerson, Jason ^c   Getz, Kenneth ^d   Wangsmo, Gary ^e   Muse, Carianne T ^f   Sugarman, Jeremy ^g  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Stevens Health   (United States)

^f BOOZ ALLEN HAMILTON   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST; ECONOMICS; INFORMATION PROCESSING; METHODOLOGY; PROFESSIONAL STANDARD; REVIEW; SALARY AND FRINGE BENEFIT; STATISTICS; UNITED STATES; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; COSTS AND COST ANALYSIS; DATA COLLECTION; ETHICS COMMITTEES, RESEARCH; SALARIES AND FRINGE BENEFITS; UNITED STATES;

EID: 34247226191     PISSN: 01937758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Christian MC, Goldberg JL, Killen J, et al. A central institutional review board for multi-institutional trials. NEJM 2002;346:1405-1408;
2. Levine RJ. Ethics and Regulation of Clinical Research. New Haven: Yale University Press, 1986:70-71;
3. Burman WJ, Reves RR, Cohn DL, et al. Breaking the camel's back: Multicenter clinical trials and local institutional review boards. Annals of Internal Medicine 2001;134:152-157;
4. Department of Health and Human Services. Institutional Review Boards: A Time for Reform. DHHS publication no. OWI-01-97-00193. Washington, DC: Office of Inspector General, 1998.
5. Institute of Medicine. Responsible Research: A Systems Approach to Protecting Research Participants. Washington, DC: National Academies Press, 2002;
6. Sugarman J, The role of institutional support in protecting human research subjects. Academic Medicine 2000;75:687-692.
7. Brown JHU, Schoenfield LS, Allan PW. The costs of an institutional review board. Journal of Medical Education 1979;54:294-299.
8. Wagner TH, Cruz AME, Chadwick GL. Economies of scale in institutional review boards. Medical Care 2004;42:817-823;
9. Wagner TH, Bhandari A, Chadwick GL, et al. The cost of operating institutional review boards (IRBs). Academic Medicine 2003;78:638-644.
10. Orloff TM, Littell CL, Clune C, et al. Hospital cost accounting: Who's doing what and why. Health Care Management Review 1990;15(4):73-78.
11. Byrne MM, Speckman J, Getz K, et al. Variability in the costs of institutional review board oversight. Academic Medicine 2006;81:708-711.
12. Jacobs P, Bachynsky J. Costing methods in the Canadian literature on the economic evaluation of health care. International Journal of Technology Assessment in Health Care 1996;12:721-734.
13. French MT, Dunlap G, Zarkin K, et al. A structured instrument for estimating the economic cost of drug abuse treatment: The Drug Abuse Treatment Cost Analysis Program (DATCAP). Journal of Substance Abuse Treatment 1997;14(4):1-11;
14. Clarke AE, Esdaile JM, Bloch DA, et al. A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs. Arthritis and Rheumatism 1993;36:1548-1559;
15. Dranove D, Sloan FA, eds. Valuing Health Care Costs: Costs, Benefits and Effectiveness of Pharmaceuticals and other Medical Technologies. Cambridge, MA: Cambridge University Press, 1996: 61-75.
16. http://www.salary.com
17. See ref. 6, Byrne et al. 2006.
18. http://www.aamc.org/members/msmr/comparativedata/compensation.htm
19. http://www.bls.gov/oes/
20. http://nces.ed.gov/pubszoO3/digestoz/tables/dt382.asp
21. Reis Inc., http://www.reis.com
22. See ref. 6, Byrne et al. 2006
23. See ref. 6, Byrne et al. 2006
24. See ref. 6, Byrne et al. 2006.